Literature DB >> 1701350

Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

H R Yu1, R M Schultz.   

Abstract

Murine melanoma B16-F1 cells of low metastatic potential were transfected with the human gene for the prepro form of urokinase in an SV40 expression vector (plasmid pSV2-uPA), and cells expressing high amounts of the human urokinase gene product were selected for by an enzyme-linked immunosorbent assay specific for human high molecular weight urokinase. Southern analysis showed one of the cell lines (clone 7) had incorporated 150 copies of the pSV2-uPA plasmid into its genomic DNA. The human urokinase synthesized by the pSV2-uPA-transfected murine B16 cells was found to be glycosylated and did not bind to the murine cell surface urokinase receptor sites. In an in vivo assay that measures metastasis from a primary tumor (spontaneous metastatic assay), clone 7 cells showed an increased ability to metastasize (12 of 12 mice showed metastatic tumors), while control cells showed a lower ability to metastasize (only 2 of 11 mice showed metastatic tumors). In a second in vivo assay, which measures only the steps of the metastatic migration process during which tumor cells extravasate from the blood and then grow into pulmonary tumors (lung colonization assay), a significant multifold increase in the ability to form lung tumors was shown by the high human urokinase-secreting B16-F1 cells. In B16-F10 cells incorporating an antisense sequence to preprourokinase (plasmid pSV1-ASuPA-265) and secreting significantly decreased amounts of murine urokinase, a corresponding significant decrease in lung colonization was observed. These results provide direct experimental support for a role of secreted (non-surface-bound) urokinase in the colonization steps of the metastatic process. Furthermore, the data indicate that the higher lung colonization ability of the B16-F10 line than of the B16-F1 line is primarily based on the quantitative differences in their abilities to produce urokinase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701350

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 2.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

3.  Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.

Authors:  L H Brail; R P Hill
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

4.  Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.

Authors:  M Osmak; I Vrhovec; J Skrk
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

5.  Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablation.

Authors:  Kasper Almholt; Anna Juncker-Jensen; Ole Didrik Lærum; Morten Johnsen; John Rømer; Leif Røge Lund
Journal:  Clin Exp Metastasis       Date:  2012-09-21       Impact factor: 5.150

Review 6.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G Dipierro; Rana Abdel-Fattah; Samson Amos; Gerard T Redpath; Joan E Carpenter; Russell O Pieper; Isa M Hussaini
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

Review 8.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

9.  Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression.

Authors:  L Bell; D J Luthringer; J A Madri; S L Warren
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

10.  Urokinase-type plasminogen activator activity increases during the growth of two murine mammary adenocarcinomas with different metastasizing abilities.

Authors:  S Pereyra-Alfonso; G R Solarz; E Bal de Kier Joffé
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.